| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Severe LV target organ damage can only be identified with LV imaging. May improve risk stratification |
| Risks, harm, cost | Adds cost; improvement in outcomes from incorporating echocardiography into clinical care is not established |
| Benefit–harm assessment | Benefits exceed harms |
| Intentional vagueness | None |
| Role of patient preferences | Patients may elect to not to have the study |
| Exclusions | None |
| Strength | Moderate recommendation |
| Key references | 361,363,364,367–369 |
| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Severe LV target organ damage can only be identified with LV imaging. May improve risk stratification |
| Risks, harm, cost | Adds cost; improvement in outcomes from incorporating echocardiography into clinical care is not established |
| Benefit–harm assessment | Benefits exceed harms |
| Intentional vagueness | None |
| Role of patient preferences | Patients may elect to not to have the study |
| Exclusions | None |
| Strength | Moderate recommendation |
| Key references | 361,363,364,367–369 |